NIEL, Belgium, March 28, 2022 (GLOBE NEWSWIRE) -- eTheRNA Manufacturing, a specialist RNA process developer and manufacturing member of the Belgian eTheRNA group, is introducing a new Lipid ...
Formulation development can involve several complex technical challenges, but an approach incorporating design of experiments can help address these difficulties. All pharmaceutical drug products are ...
Unique solutions are required to protect inherently unstable messenger RNA. Oligonucleotide drug substances generally are unstable at room temperature, and some are also degraded in the presence of ...
The strategic partnership will establish a joint solution for the efficient creation of buffers created from concentrates delivered directly to manufacturing facilities, increasing productivity and ...
The success of the mRNA vaccines for COVID-19 led to explosive growth in lipid nanoparticle (LNP)-mediated drug delivery for RNA vaccines and therapeutics. As these projects scale into clinical trials ...
Artificial intelligence is helping transform engineering polymers by accelerating material development, optimizing ...
Discover how petrochemical and formulated-product leaders are using Siemens Xcelerator to connect formulation, manufacturing, quality, and compliance into a unified digital thread—accelerating ...
Nanoform (Finland), an innovative nanoparticle medicine enabling company, today announced it has signed a GMP 1 manufacturing program (clinical development) to enhance TargTex’s Glioblastoma ...
Formulation differentiates therapies in crowded markets by improving adherence, tolerability, convenience, and delivery efficiency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results